

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.35246586 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.35246586 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.18187103 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.18187103 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.79402873 |
| 6 | signal peptide processing (GO:0006465) | 5.56519238 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.32646851 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.29532269 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.29532269 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.29532269 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.11002305 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07446237 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.06224581 |
| 14 | cysteine metabolic process (GO:0006534) | 4.91180341 |
| 15 | urea cycle (GO:0000050) | 4.88970072 |
| 16 | urea metabolic process (GO:0019627) | 4.88970072 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.84511590 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.81280434 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.68309594 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 4.65708228 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.60559551 |
| 22 | lysine metabolic process (GO:0006553) | 4.49125171 |
| 23 | lysine catabolic process (GO:0006554) | 4.49125171 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.46659414 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37541066 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.25221166 |
| 27 | reverse cholesterol transport (GO:0043691) | 4.20232422 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.20066733 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.18900448 |
| 30 | behavioral response to nicotine (GO:0035095) | 4.18339590 |
| 31 | protein carboxylation (GO:0018214) | 4.17453257 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.17453257 |
| 33 | L-fucose catabolic process (GO:0042355) | 4.14724882 |
| 34 | fucose catabolic process (GO:0019317) | 4.14724882 |
| 35 | L-fucose metabolic process (GO:0042354) | 4.14724882 |
| 36 | bile acid metabolic process (GO:0008206) | 4.14526999 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.09996966 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.09996966 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.02948376 |
| 40 | positive regulation of respiratory burst (GO:0060267) | 4.01382729 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.00057885 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.00057885 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 3.98336013 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 3.96918762 |
| 45 | complement activation, alternative pathway (GO:0006957) | 3.95223611 |
| 46 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.94139803 |
| 47 | drug catabolic process (GO:0042737) | 3.93005776 |
| 48 | bile acid and bile salt transport (GO:0015721) | 3.91979889 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 3.90781807 |
| 50 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.89756098 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89622653 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 3.89622653 |
| 53 | macromolecular complex remodeling (GO:0034367) | 3.89622653 |
| 54 | tyrosine metabolic process (GO:0006570) | 3.87306787 |
| 55 | phospholipid efflux (GO:0033700) | 3.86952379 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.85000208 |
| 57 | regulation of protein activation cascade (GO:2000257) | 3.84424878 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 3.81758269 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.77911482 |
| 60 | drug transmembrane transport (GO:0006855) | 3.77128297 |
| 61 | response to pheromone (GO:0019236) | 3.76404383 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.70796386 |
| 63 | intestinal cholesterol absorption (GO:0030299) | 3.70104910 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.68057971 |
| 65 | cellular glucuronidation (GO:0052695) | 3.67690637 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.67397796 |
| 67 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.64977844 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 3.64321745 |
| 69 | ethanol oxidation (GO:0006069) | 3.62232731 |
| 70 | kidney morphogenesis (GO:0060993) | 3.60806245 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.59663745 |
| 72 | cilium movement (GO:0003341) | 3.59302426 |
| 73 | urate metabolic process (GO:0046415) | 3.56581741 |
| 74 | regulation of complement activation (GO:0030449) | 3.54307379 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.52305498 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.48492950 |
| 77 | epithelial cilium movement (GO:0003351) | 3.48450824 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.47973420 |
| 79 | axoneme assembly (GO:0035082) | 3.46139504 |
| 80 | cytidine catabolic process (GO:0006216) | 3.44220530 |
| 81 | cytidine deamination (GO:0009972) | 3.44220530 |
| 82 | cytidine metabolic process (GO:0046087) | 3.44220530 |
| 83 | arginine metabolic process (GO:0006525) | 3.43470389 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.43054707 |
| 85 | amine catabolic process (GO:0009310) | 3.43054707 |
| 86 | glutamate metabolic process (GO:0006536) | 3.42443263 |
| 87 | fatty acid oxidation (GO:0019395) | 3.41906567 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.41905947 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.40936502 |
| 90 | intestinal absorption (GO:0050892) | 3.38762011 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.38591703 |
| 92 | valine metabolic process (GO:0006573) | 3.37997836 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.37660463 |
| 94 | cholesterol efflux (GO:0033344) | 3.37047446 |
| 95 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.36587298 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.36201572 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.35192451 |
| 98 | sterol homeostasis (GO:0055092) | 3.34420517 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.33924223 |
| 100 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.33805776 |
| 101 | lipid oxidation (GO:0034440) | 3.33765939 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 3.33668328 |
| 103 | thyroid hormone metabolic process (GO:0042403) | 3.31786218 |
| 104 | cobalamin metabolic process (GO:0009235) | 3.31375553 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.30950649 |
| 106 | ketone body metabolic process (GO:1902224) | 3.30888952 |
| 107 | intestinal epithelial cell development (GO:0060576) | 3.30685248 |
| 108 | axonemal dynein complex assembly (GO:0070286) | 3.30474142 |
| 109 | coenzyme catabolic process (GO:0009109) | 3.30442441 |
| 110 | response to nitrosative stress (GO:0051409) | 3.29519156 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.28006520 |
| 112 | uronic acid metabolic process (GO:0006063) | 3.28006520 |
| 113 | endocrine pancreas development (GO:0031018) | 3.26190045 |
| 114 | digestion (GO:0007586) | 3.25960778 |
| 115 | fatty acid catabolic process (GO:0009062) | 3.22701214 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.22627182 |
| 117 | organic acid catabolic process (GO:0016054) | 3.22627182 |
| 118 | monocarboxylic acid catabolic process (GO:0072329) | 3.22203229 |
| 119 | protein-lipid complex assembly (GO:0065005) | 3.21856751 |
| 120 | glycine metabolic process (GO:0006544) | 3.21690286 |
| 121 | regulation of guanylate cyclase activity (GO:0031282) | 3.19665509 |
| 122 | reflex (GO:0060004) | 3.17209240 |
| 123 | exogenous drug catabolic process (GO:0042738) | 3.15628040 |
| 124 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.14276709 |
| 125 | nucleobase catabolic process (GO:0046113) | 3.13742719 |
| 126 | sulfate transmembrane transport (GO:1902358) | 3.08792580 |
| 127 | serotonin metabolic process (GO:0042428) | 3.07280819 |
| 128 | negative regulation of neurological system process (GO:0031645) | 3.06131412 |
| 129 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.06094941 |
| 130 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.02457358 |
| 131 | sphingoid metabolic process (GO:0046519) | 3.01258394 |
| 132 | auditory receptor cell differentiation (GO:0042491) | 2.99471808 |
| 133 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95591812 |
| 134 | regulation of hexokinase activity (GO:1903299) | 2.93337988 |
| 135 | regulation of glucokinase activity (GO:0033131) | 2.93337988 |
| 136 | primary amino compound metabolic process (GO:1901160) | 2.91788425 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.90618404 |
| 138 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.85969162 |
| 139 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.85667867 |
| 140 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.85557626 |
| 141 | gamma-aminobutyric acid transport (GO:0015812) | 2.79675684 |
| 142 | nucleotide transmembrane transport (GO:1901679) | 2.79659194 |
| 143 | protein import into peroxisome matrix (GO:0016558) | 2.78868759 |
| 144 | sulfate transport (GO:0008272) | 2.78607239 |
| 145 | proline transport (GO:0015824) | 2.78383055 |
| 146 | hemidesmosome assembly (GO:0031581) | 2.78249254 |
| 147 | regulation of respiratory burst (GO:0060263) | 2.76057392 |
| 148 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.75003066 |
| 149 | snRNA transcription (GO:0009301) | 2.73765978 |
| 150 | thyroid hormone generation (GO:0006590) | 2.68316324 |
| 151 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.67810019 |
| 152 | negative regulation of osteoblast proliferation (GO:0033689) | 2.65839367 |
| 153 | sulfur compound transport (GO:0072348) | 2.63673333 |
| 154 | photoreceptor cell maintenance (GO:0045494) | 2.61445641 |
| 155 | rRNA catabolic process (GO:0016075) | 2.61019103 |
| 156 | positive regulation of protein homooligomerization (GO:0032464) | 2.60824710 |
| 157 | diol metabolic process (GO:0034311) | 2.60196319 |
| 158 | neuronal action potential (GO:0019228) | 2.59997881 |
| 159 | regulation of keratinocyte proliferation (GO:0010837) | 2.59016871 |
| 160 | O-glycan processing (GO:0016266) | 2.58849767 |
| 161 | keratinocyte development (GO:0003334) | 2.58275716 |
| 162 | flavonoid metabolic process (GO:0009812) | 2.56374944 |
| 163 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.55461571 |
| 164 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.55461571 |
| 165 | behavioral response to ethanol (GO:0048149) | 2.53909439 |
| 166 | neurotransmitter metabolic process (GO:0042133) | 2.53618998 |
| 167 | detection of light stimulus involved in visual perception (GO:0050908) | 2.52001621 |
| 168 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.52001621 |
| 169 | sphingosine metabolic process (GO:0006670) | 2.47690259 |
| 170 | sulfation (GO:0051923) | 2.47594717 |
| 171 | cilium organization (GO:0044782) | 2.47525806 |
| 172 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.46528730 |
| 173 | protein localization to cilium (GO:0061512) | 2.45422690 |
| 174 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.45355315 |
| 175 | negative regulation of bone resorption (GO:0045779) | 2.44059578 |
| 176 | transepithelial transport (GO:0070633) | 2.43907274 |
| 177 | DNA deamination (GO:0045006) | 2.43485173 |
| 178 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.41428638 |
| 179 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.41026981 |
| 180 | desmosome organization (GO:0002934) | 2.40710893 |
| 181 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.40320012 |
| 182 | positive regulation of glycolytic process (GO:0045821) | 2.39139157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.27469057 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.87530586 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.09777241 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.42253874 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41085800 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76954336 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.87479757 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.79731458 |
| 9 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.75464894 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.29396094 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.07798216 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.92777202 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.70721150 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.56394649 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.53303413 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.44265383 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42574100 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42564128 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.30028773 |
| 20 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25980594 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.25509520 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24611488 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18492320 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12859512 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06678993 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.05980344 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98187493 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.97827122 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95439656 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.93821138 |
| 31 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.93672081 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93516544 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89178402 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.84843068 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83999617 |
| 36 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.83618730 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80721749 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.79667066 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73402762 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.71489512 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71270502 |
| 42 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.68787022 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65732364 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65192495 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63293138 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58560333 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.58468178 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57022153 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55554183 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55511225 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55393017 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55393017 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54606546 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.54217142 |
| 55 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54085889 |
| 56 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.53698061 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53294870 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51272475 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48620661 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46978538 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46938142 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44133059 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43739401 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42104668 |
| 65 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.41528440 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39028936 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38151205 |
| 68 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38041937 |
| 69 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37665616 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37649759 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37087531 |
| 72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36808835 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36476445 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36265868 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35406777 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35012988 |
| 77 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33584649 |
| 78 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33584649 |
| 79 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32340319 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31818510 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31177697 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30528990 |
| 83 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.29893474 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29848491 |
| 85 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.28343318 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27239378 |
| 87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27239378 |
| 88 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.26881047 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25694655 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25044318 |
| 91 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24568475 |
| 92 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24401112 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23902521 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23688457 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23654395 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22990462 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22310441 |
| 98 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22140066 |
| 99 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21794540 |
| 100 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19047197 |
| 101 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18006176 |
| 102 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17243124 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16774165 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16774165 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14958254 |
| 106 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14641350 |
| 107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14581221 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12613792 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12416190 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12007646 |
| 111 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11931637 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10996062 |
| 113 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.10051492 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09994309 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09672601 |
| 116 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09620166 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.09172845 |
| 118 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08838008 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08247643 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07551929 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07131640 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05673945 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05043509 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04006513 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99793715 |
| 126 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98685972 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98103324 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96867581 |
| 129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96080035 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92548663 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91199055 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90704014 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87515497 |
| 134 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86717097 |
| 135 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86232647 |
| 136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86232647 |
| 137 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85636773 |
| 138 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85636773 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82879251 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82225358 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81556542 |
| 142 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80369209 |
| 143 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78509767 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78194591 |
| 145 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78111589 |
| 146 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77148207 |
| 147 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77140291 |
| 148 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.76960287 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76680261 |
| 150 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.76198314 |
| 151 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75300646 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74852736 |
| 153 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74373153 |
| 154 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73871718 |
| 155 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69838476 |
| 156 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.69357771 |
| 157 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.68541340 |
| 158 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68386820 |
| 159 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67973180 |
| 160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67925091 |
| 161 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.67840853 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.67425840 |
| 163 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.67287864 |
| 164 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66269478 |
| 165 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.65534020 |
| 166 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.65144660 |
| 167 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.64946953 |
| 168 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64916646 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64409198 |
| 170 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64360975 |
| 171 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.63947060 |
| 172 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.63873604 |
| 173 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62677309 |
| 174 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62476527 |
| 175 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.61261105 |
| 176 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60684995 |
| 177 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60446435 |
| 178 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60033800 |
| 179 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59835058 |
| 180 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.59216196 |
| 181 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57507377 |
| 182 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57353820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.67815777 |
| 2 | MP0005360_urolithiasis | 6.32871916 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.39805514 |
| 4 | MP0005365_abnormal_bile_salt | 5.00066539 |
| 5 | MP0004147_increased_porphyrin_level | 4.22214480 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86417193 |
| 7 | MP0003252_abnormal_bile_duct | 3.63681405 |
| 8 | MP0002254_reproductive_system_inflammat | 3.25661223 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.23503781 |
| 10 | MP0003195_calcinosis | 3.02570422 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.92647032 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.80094677 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.60522105 |
| 14 | MP0005332_abnormal_amino_acid | 2.58883115 |
| 15 | MP0005083_abnormal_biliary_tract | 2.45904065 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.37394165 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.35991217 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.35874242 |
| 19 | MP0009840_abnormal_foam_cell | 2.22041603 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.21826763 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.16020154 |
| 22 | MP0000383_abnormal_hair_follicle | 1.99931903 |
| 23 | MP0000609_abnormal_liver_physiology | 1.97713280 |
| 24 | MP0008872_abnormal_physiological_respon | 1.95527518 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.91365083 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.88057421 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.78751678 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.78153587 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.76517353 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.74912869 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.74523970 |
| 32 | MP0003868_abnormal_feces_composition | 1.69939697 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.68962881 |
| 34 | MP0004885_abnormal_endolymph | 1.61703737 |
| 35 | MP0005310_abnormal_salivary_gland | 1.55240333 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.54396913 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.52084480 |
| 38 | MP0009046_muscle_twitch | 1.47845139 |
| 39 | MP0004043_abnormal_pH_regulation | 1.47059330 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.45716493 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.45013415 |
| 42 | MP0002163_abnormal_gland_morphology | 1.44864973 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.42710074 |
| 44 | MP0002822_catalepsy | 1.42419846 |
| 45 | MP0008057_abnormal_DNA_replication | 1.41854851 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 1.39798490 |
| 47 | MP0001764_abnormal_homeostasis | 1.39294772 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.38756497 |
| 49 | MP0003787_abnormal_imprinting | 1.37873249 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.35320194 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.30959747 |
| 52 | MP0003045_fibrosis | 1.30004400 |
| 53 | MP0003866_abnormal_defecation | 1.28014426 |
| 54 | MP0001881_abnormal_mammary_gland | 1.27104507 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.26273744 |
| 56 | MP0001664_abnormal_digestion | 1.26089183 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.23506974 |
| 58 | MP0002102_abnormal_ear_morphology | 1.21818993 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20251366 |
| 60 | MP0001756_abnormal_urination | 1.19392168 |
| 61 | MP0009697_abnormal_copulation | 1.18684272 |
| 62 | MP0000631_abnormal_neuroendocrine_gland | 1.15977216 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.15839876 |
| 64 | MP0001188_hyperpigmentation | 1.15768149 |
| 65 | MP0000685_abnormal_immune_system | 1.14964476 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.12874896 |
| 67 | MP0001984_abnormal_olfaction | 1.10796056 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.09430810 |
| 69 | MP0000598_abnormal_liver_morphology | 1.07052951 |
| 70 | MP0003186_abnormal_redox_activity | 1.06204089 |
| 71 | MP0005451_abnormal_body_composition | 1.05434111 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.05378773 |
| 73 | MP0009745_abnormal_behavioral_response | 1.04092285 |
| 74 | MP0003283_abnormal_digestive_organ | 1.03585361 |
| 75 | MP0000538_abnormal_urinary_bladder | 1.02859133 |
| 76 | MP0000566_synostosis | 1.02786451 |
| 77 | MP0000470_abnormal_stomach_morphology | 1.02336716 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.01354277 |
| 79 | MP0002796_impaired_skin_barrier | 1.00959051 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 1.00503964 |
| 81 | MP0001800_abnormal_humoral_immune | 1.00423708 |
| 82 | MP0003718_maternal_effect | 1.00068077 |
| 83 | MP0004924_abnormal_behavior | 0.99027977 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.99027977 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.98250704 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.98122024 |
| 87 | MP0005671_abnormal_response_to | 0.96156921 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.95951872 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.95491796 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.92224154 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.91580381 |
| 92 | MP0005408_hypopigmentation | 0.89146820 |
| 93 | MP0002272_abnormal_nervous_system | 0.88754478 |
| 94 | MP0005389_reproductive_system_phenotype | 0.87480302 |
| 95 | MP0001970_abnormal_pain_threshold | 0.87249131 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.86372626 |
| 97 | MP0003646_muscle_fatigue | 0.86239313 |
| 98 | MP0002557_abnormal_social/conspecific_i | 0.85996115 |
| 99 | MP0001873_stomach_inflammation | 0.85077543 |
| 100 | MP0005647_abnormal_sex_gland | 0.83749439 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.83228711 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.82831617 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.81569037 |
| 104 | MP0001919_abnormal_reproductive_system | 0.81433702 |
| 105 | MP0006276_abnormal_autonomic_nervous | 0.80837061 |
| 106 | MP0003011_delayed_dark_adaptation | 0.79940642 |
| 107 | MP0004133_heterotaxia | 0.79909759 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.79570412 |
| 109 | MP0004142_abnormal_muscle_tone | 0.78009373 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.77955286 |
| 111 | MP0009764_decreased_sensitivity_to | 0.77273770 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.77030644 |
| 113 | MP0002733_abnormal_thermal_nociception | 0.77001811 |
| 114 | MP0005253_abnormal_eye_physiology | 0.75942114 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.75888902 |
| 116 | MP0008469_abnormal_protein_level | 0.75783078 |
| 117 | MP0002060_abnormal_skin_morphology | 0.75535280 |
| 118 | MP0002928_abnormal_bile_duct | 0.75123620 |
| 119 | MP0003941_abnormal_skin_development | 0.75098647 |
| 120 | MP0001835_abnormal_antigen_presentation | 0.74881997 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.74276565 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.74137411 |
| 123 | MP0000579_abnormal_nail_morphology | 0.73786001 |
| 124 | MP0002006_tumorigenesis | 0.73780920 |
| 125 | MP0002971_abnormal_brown_adipose | 0.73244410 |
| 126 | MP0003879_abnormal_hair_cell | 0.72669502 |
| 127 | MP0010678_abnormal_skin_adnexa | 0.72591318 |
| 128 | MP0009763_increased_sensitivity_to | 0.71084456 |
| 129 | MP0005670_abnormal_white_adipose | 0.69829291 |
| 130 | MP0000427_abnormal_hair_cycle | 0.67465592 |
| 131 | MP0000604_amyloidosis | 0.66378181 |
| 132 | MP0006054_spinal_hemorrhage | 0.64402339 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.64333625 |
| 134 | MP0000613_abnormal_salivary_gland | 0.64105346 |
| 135 | MP0001853_heart_inflammation | 0.63314724 |
| 136 | MP0000013_abnormal_adipose_tissue | 0.61591954 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.59989159 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.57529015 |
| 139 | MP0005448_abnormal_energy_balance | 0.57482682 |
| 140 | MP0003959_abnormal_lean_body | 0.57211854 |
| 141 | MP0010155_abnormal_intestine_physiology | 0.57074873 |
| 142 | MP0009053_abnormal_anal_canal | 0.57035410 |
| 143 | MP0004947_skin_inflammation | 0.56879346 |
| 144 | MP0005334_abnormal_fat_pad | 0.56381386 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.55449619 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.55211728 |
| 147 | MP0006036_abnormal_mitochondrial_physio | 0.55195039 |
| 148 | MP0005023_abnormal_wound_healing | 0.54110511 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.53111547 |
| 150 | MP0002168_other_aberrant_phenotype | 0.50871472 |
| 151 | MP0005501_abnormal_skin_physiology | 0.50651602 |
| 152 | MP0001790_abnormal_immune_system | 0.50159403 |
| 153 | MP0005387_immune_system_phenotype | 0.50159403 |
| 154 | MP0003566_abnormal_cell_adhesion | 0.49937819 |
| 155 | MP0005266_abnormal_metabolism | 0.49662080 |
| 156 | MP0003953_abnormal_hormone_level | 0.49308420 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.48840180 |
| 158 | MP0005395_other_phenotype | 0.48830466 |
| 159 | MP0001661_extended_life_span | 0.48249777 |
| 160 | MP0009785_altered_susceptibility_to | 0.47283110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.20660200 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.12376445 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.48564283 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.27532686 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.26270538 |
| 6 | Xanthomatosis (HP:0000991) | 5.05381906 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.04320394 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.65523850 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.56306212 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 4.10869067 |
| 11 | Hydroxyprolinuria (HP:0003080) | 4.10869067 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.98396637 |
| 13 | Epidermoid cyst (HP:0200040) | 3.91136933 |
| 14 | Hyperammonemia (HP:0001987) | 3.87094020 |
| 15 | Fat malabsorption (HP:0002630) | 3.81121728 |
| 16 | Abnormality of purine metabolism (HP:0004352) | 3.79937534 |
| 17 | Ketosis (HP:0001946) | 3.68237366 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.64075925 |
| 19 | Hyperglycinuria (HP:0003108) | 3.62153666 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.59842342 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59587079 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55418815 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.53604013 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48230451 |
| 25 | Decreased circulating renin level (HP:0003351) | 3.48039720 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.41852543 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.37025442 |
| 28 | Chronic hepatic failure (HP:0100626) | 3.36061971 |
| 29 | Abnormality of nucleobase metabolism (HP:0010932) | 3.35680588 |
| 30 | Complement deficiency (HP:0004431) | 3.35429253 |
| 31 | Pancreatic cysts (HP:0001737) | 3.31330527 |
| 32 | Ketoacidosis (HP:0001993) | 3.30928297 |
| 33 | Gout (HP:0001997) | 3.25960624 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.22747814 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.22747814 |
| 36 | Hyperglycinemia (HP:0002154) | 3.18763355 |
| 37 | Abnormality of renin-angiotensin system (HP:0000847) | 3.18326152 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.13348501 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13139511 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.09619339 |
| 41 | Joint hemorrhage (HP:0005261) | 3.07380286 |
| 42 | Hypoglycemic seizures (HP:0002173) | 3.04816230 |
| 43 | Increased purine levels (HP:0004368) | 3.03198572 |
| 44 | Hyperuricemia (HP:0002149) | 3.03198572 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.99731449 |
| 46 | Chronic bronchitis (HP:0004469) | 2.99232099 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.98465828 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.93925457 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.92203367 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.92203367 |
| 51 | Bronchiectasis (HP:0002110) | 2.88762752 |
| 52 | Alkalosis (HP:0001948) | 2.86683147 |
| 53 | Malnutrition (HP:0004395) | 2.83147280 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.81939272 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.81834575 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.80257559 |
| 57 | Vascular calcification (HP:0004934) | 2.78660246 |
| 58 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.77802636 |
| 59 | Absent/shortened dynein arms (HP:0200106) | 2.77802636 |
| 60 | Tubular atrophy (HP:0000092) | 2.77550756 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.77349541 |
| 62 | Recurrent sinusitis (HP:0011108) | 2.76986805 |
| 63 | True hermaphroditism (HP:0010459) | 2.75827060 |
| 64 | Abnormal pancreas size (HP:0012094) | 2.74594680 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.69901734 |
| 66 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.66255966 |
| 67 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.66255966 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65811401 |
| 69 | Abnormality of methionine metabolism (HP:0010901) | 2.64271706 |
| 70 | Abnormality of chloride homeostasis (HP:0011422) | 2.64093370 |
| 71 | Abnormality of the renal medulla (HP:0100957) | 2.63874069 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.63492459 |
| 73 | Steatorrhea (HP:0002570) | 2.61018540 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60747084 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.60747084 |
| 76 | Nephronophthisis (HP:0000090) | 2.59509328 |
| 77 | Skin nodule (HP:0200036) | 2.58022791 |
| 78 | Hyperglycemia (HP:0003074) | 2.58003955 |
| 79 | Spontaneous abortion (HP:0005268) | 2.56167742 |
| 80 | Gaze-evoked nystagmus (HP:0000640) | 2.54794060 |
| 81 | Hyperventilation (HP:0002883) | 2.53339466 |
| 82 | Esophageal varix (HP:0002040) | 2.52438447 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.52407969 |
| 84 | Hyperaldosteronism (HP:0000859) | 2.50469524 |
| 85 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.50101426 |
| 86 | Hypokalemic alkalosis (HP:0001949) | 2.49957723 |
| 87 | Abnormality of complement system (HP:0005339) | 2.49738558 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.49253785 |
| 89 | Abnormal ciliary motility (HP:0012262) | 2.49119765 |
| 90 | Bronchitis (HP:0012387) | 2.48576276 |
| 91 | Large for gestational age (HP:0001520) | 2.48045663 |
| 92 | Chronic diarrhea (HP:0002028) | 2.47450525 |
| 93 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47166696 |
| 94 | Rhinitis (HP:0012384) | 2.46731182 |
| 95 | Metabolic acidosis (HP:0001942) | 2.43081304 |
| 96 | Symptomatic seizures (HP:0011145) | 2.42640473 |
| 97 | Myocardial infarction (HP:0001658) | 2.41917053 |
| 98 | Plantar hyperkeratosis (HP:0007556) | 2.41348475 |
| 99 | Hypoplasia of the uterus (HP:0000013) | 2.38412277 |
| 100 | Hypoplastic labia majora (HP:0000059) | 2.37144253 |
| 101 | Abnormality of vitamin B metabolism (HP:0004340) | 2.34282286 |
| 102 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.33516992 |
| 103 | Acanthocytosis (HP:0001927) | 2.33302616 |
| 104 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.33210988 |
| 105 | Hypothermia (HP:0002045) | 2.30220298 |
| 106 | Lethargy (HP:0001254) | 2.29325938 |
| 107 | Glycosuria (HP:0003076) | 2.26447536 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.26447536 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.25862944 |
| 110 | Spastic diplegia (HP:0001264) | 2.24720103 |
| 111 | Congenital sensorineural hearing impairment (HP:0008527) | 2.23548668 |
| 112 | Metabolic alkalosis (HP:0200114) | 2.22865791 |
| 113 | Genetic anticipation (HP:0003743) | 2.21138360 |
| 114 | Abnormal drinking behavior (HP:0030082) | 2.20262813 |
| 115 | Polydipsia (HP:0001959) | 2.20262813 |
| 116 | Irritability (HP:0000737) | 2.20019884 |
| 117 | Late onset (HP:0003584) | 2.15118593 |
| 118 | Abnormality of the labia majora (HP:0012881) | 2.14845201 |
| 119 | Recurrent bronchitis (HP:0002837) | 2.13750397 |
| 120 | Abnormality of serum amino acid levels (HP:0003112) | 2.11425053 |
| 121 | Delayed CNS myelination (HP:0002188) | 2.11106258 |
| 122 | Cystic liver disease (HP:0006706) | 2.10837157 |
| 123 | Hyperkalemia (HP:0002153) | 2.10089007 |
| 124 | Abnormality of the renal collecting system (HP:0004742) | 2.08767533 |
| 125 | Attenuation of retinal blood vessels (HP:0007843) | 2.08142326 |
| 126 | Furrowed tongue (HP:0000221) | 2.07917470 |
| 127 | Exocrine pancreatic insufficiency (HP:0001738) | 2.07887797 |
| 128 | Onycholysis (HP:0001806) | 2.07801841 |
| 129 | Ileus (HP:0002595) | 2.05801180 |
| 130 | Milia (HP:0001056) | 2.05302503 |
| 131 | Abdominal distention (HP:0003270) | 2.04666982 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 2.02215008 |
| 133 | Pancreatitis (HP:0001733) | 2.00455224 |
| 134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98622566 |
| 135 | Decreased central vision (HP:0007663) | 1.97809467 |
| 136 | Elevated hepatic transaminases (HP:0002910) | 1.97280365 |
| 137 | Mitral stenosis (HP:0001718) | 1.96572929 |
| 138 | Cholelithiasis (HP:0001081) | 1.96472702 |
| 139 | Vomiting (HP:0002013) | 1.95893564 |
| 140 | Agammaglobulinemia (HP:0004432) | 1.95666392 |
| 141 | Agitation (HP:0000713) | 1.94236089 |
| 142 | Chronic sinusitis (HP:0011109) | 1.94210874 |
| 143 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93477909 |
| 144 | Opisthotonus (HP:0002179) | 1.91771802 |
| 145 | Duplicated collecting system (HP:0000081) | 1.91611232 |
| 146 | Protuberant abdomen (HP:0001538) | 1.91289448 |
| 147 | Brushfield spots (HP:0001088) | 1.91058306 |
| 148 | Glomerulosclerosis (HP:0000096) | 1.89688726 |
| 149 | Renal salt wasting (HP:0000127) | 1.87278257 |
| 150 | Dehydration (HP:0001944) | 1.86828905 |
| 151 | Lip pit (HP:0100267) | 1.86590958 |
| 152 | Enlarged kidneys (HP:0000105) | 1.86053698 |
| 153 | Medial flaring of the eyebrow (HP:0010747) | 1.85979472 |
| 154 | Renal cortical cysts (HP:0000803) | 1.85106586 |
| 155 | Thyroiditis (HP:0100646) | 1.84157143 |
| 156 | Progressive cerebellar ataxia (HP:0002073) | 1.83796134 |
| 157 | Stomach cancer (HP:0012126) | 1.83665800 |
| 158 | Pili torti (HP:0003777) | 1.82373900 |
| 159 | Neonatal onset (HP:0003623) | 1.82078337 |
| 160 | Elevated alkaline phosphatase (HP:0003155) | 1.80867058 |
| 161 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80122802 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.80114628 |
| 163 | Abnormality of macular pigmentation (HP:0008002) | 1.79777968 |
| 164 | Abnormality of the gallbladder (HP:0005264) | 1.79619808 |
| 165 | Menorrhagia (HP:0000132) | 1.77617849 |
| 166 | Methylmalonic aciduria (HP:0012120) | 1.77052461 |
| 167 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75966219 |
| 168 | Congenital, generalized hypertrichosis (HP:0004540) | 1.75686177 |
| 169 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.75271340 |
| 170 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.75271340 |
| 171 | Fragile nails (HP:0001808) | 1.75241774 |
| 172 | Goiter (HP:0000853) | 1.75211411 |
| 173 | Palmoplantar hyperkeratosis (HP:0000972) | 1.74551124 |
| 174 | Broad-based gait (HP:0002136) | 1.74514478 |
| 175 | Abnormality of vitamin metabolism (HP:0100508) | 1.74334856 |
| 176 | Labial hypoplasia (HP:0000066) | 1.74115202 |
| 177 | Abnormality of renal excretion (HP:0011036) | 1.73677169 |
| 178 | Nausea (HP:0002018) | 1.73262677 |
| 179 | Cerebral edema (HP:0002181) | 1.72678664 |
| 180 | Fair hair (HP:0002286) | 1.72537524 |
| 181 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71804282 |
| 182 | Methylmalonic acidemia (HP:0002912) | 1.70614577 |
| 183 | Abnormality of potassium homeostasis (HP:0011042) | 1.70439969 |
| 184 | Hypoalbuminemia (HP:0003073) | 1.70245115 |
| 185 | Abnormal albumin level (HP:0012116) | 1.70245115 |
| 186 | Palmar hyperkeratosis (HP:0010765) | 1.69472319 |
| 187 | Abnormality of B cell number (HP:0010975) | 1.68929425 |
| 188 | Abnormal hair laboratory examination (HP:0003328) | 1.68546827 |
| 189 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.68166494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.01294825 |
| 2 | ERN1 | 3.96001411 |
| 3 | ACVR1B | 3.60157729 |
| 4 | BCKDK | 3.54802948 |
| 5 | WNK3 | 3.43292726 |
| 6 | EPHA2 | 3.25637163 |
| 7 | STK39 | 2.99691423 |
| 8 | EIF2AK3 | 2.82976919 |
| 9 | ADRBK2 | 2.68830414 |
| 10 | INSRR | 2.61659972 |
| 11 | SIK1 | 2.60491138 |
| 12 | PTK6 | 2.45858722 |
| 13 | LATS1 | 2.40032785 |
| 14 | TLK1 | 2.31817952 |
| 15 | FGFR4 | 2.26672324 |
| 16 | TRIM28 | 2.21322959 |
| 17 | STK24 | 2.07423245 |
| 18 | MST1R | 2.03971793 |
| 19 | CASK | 2.03703711 |
| 20 | PIK3CG | 1.88922803 |
| 21 | PTK2 | 1.84168733 |
| 22 | MST4 | 1.74673393 |
| 23 | MAP3K14 | 1.66784737 |
| 24 | TAOK3 | 1.63157411 |
| 25 | LMTK2 | 1.58184371 |
| 26 | TRIB3 | 1.56565378 |
| 27 | ERBB4 | 1.54029053 |
| 28 | WNK4 | 1.48921142 |
| 29 | FLT3 | 1.48226589 |
| 30 | MAPK15 | 1.45973985 |
| 31 | DDR2 | 1.45826344 |
| 32 | STK38L | 1.41085544 |
| 33 | MAP4K2 | 1.39079679 |
| 34 | PKN2 | 1.38069850 |
| 35 | ZAK | 1.36725785 |
| 36 | TESK1 | 1.31254096 |
| 37 | TBK1 | 1.31181486 |
| 38 | PRKG2 | 1.23516498 |
| 39 | NEK9 | 1.22982299 |
| 40 | PRKCI | 1.21491198 |
| 41 | BRSK2 | 1.19510116 |
| 42 | FER | 1.18812747 |
| 43 | EPHB2 | 1.18043025 |
| 44 | MAP2K2 | 1.16894385 |
| 45 | EPHA3 | 1.16793834 |
| 46 | IRAK3 | 1.14721849 |
| 47 | TYK2 | 1.13047440 |
| 48 | MET | 1.11028875 |
| 49 | EPHB1 | 1.07523252 |
| 50 | DYRK1B | 1.06983128 |
| 51 | MAP3K4 | 1.06756687 |
| 52 | NUAK1 | 1.06586554 |
| 53 | PINK1 | 1.05976490 |
| 54 | TNIK | 1.03655861 |
| 55 | MAP3K2 | 1.01206433 |
| 56 | SIK3 | 0.99435182 |
| 57 | DAPK2 | 0.98248456 |
| 58 | LRRK2 | 0.96406282 |
| 59 | MAP3K3 | 0.95117161 |
| 60 | OXSR1 | 0.94228220 |
| 61 | TGFBR1 | 0.92512329 |
| 62 | PRKAA2 | 0.89209641 |
| 63 | MAP2K1 | 0.88650843 |
| 64 | PRKCE | 0.88467931 |
| 65 | MAPK13 | 0.87835078 |
| 66 | SIK2 | 0.87790592 |
| 67 | ADRBK1 | 0.86255389 |
| 68 | MAPK11 | 0.84569789 |
| 69 | MAP3K9 | 0.84435771 |
| 70 | IRAK1 | 0.84357099 |
| 71 | RIPK1 | 0.82186588 |
| 72 | RPS6KA4 | 0.81750479 |
| 73 | PIK3CA | 0.81244422 |
| 74 | CAMKK2 | 0.80045652 |
| 75 | CHUK | 0.79852984 |
| 76 | BTK | 0.79592010 |
| 77 | RPS6KB2 | 0.79068274 |
| 78 | ERBB3 | 0.76788391 |
| 79 | CDC42BPA | 0.75400549 |
| 80 | JAK2 | 0.75367137 |
| 81 | PAK3 | 0.74372419 |
| 82 | MKNK2 | 0.74260120 |
| 83 | NME1 | 0.72268705 |
| 84 | ERBB2 | 0.72071438 |
| 85 | STK10 | 0.71532535 |
| 86 | DYRK2 | 0.70805395 |
| 87 | ITK | 0.70597833 |
| 88 | SCYL2 | 0.68163531 |
| 89 | BMPR1B | 0.67949613 |
| 90 | MAPKAPK3 | 0.67739614 |
| 91 | JAK3 | 0.66850470 |
| 92 | MAP4K1 | 0.65843379 |
| 93 | MAP3K7 | 0.61530851 |
| 94 | KIT | 0.61271401 |
| 95 | GRK6 | 0.60177949 |
| 96 | CSNK1A1 | 0.57139176 |
| 97 | TXK | 0.57079867 |
| 98 | NLK | 0.56865137 |
| 99 | IKBKE | 0.56015883 |
| 100 | PRKCH | 0.54613932 |
| 101 | FGFR2 | 0.54276305 |
| 102 | PDK2 | 0.54212671 |
| 103 | GRK1 | 0.53447951 |
| 104 | MAP3K12 | 0.53154403 |
| 105 | SGK2 | 0.53138491 |
| 106 | CAMK1D | 0.52403985 |
| 107 | IRAK4 | 0.52251202 |
| 108 | CSK | 0.51703202 |
| 109 | PRKCG | 0.50535187 |
| 110 | CSF1R | 0.50505996 |
| 111 | CDK6 | 0.50489826 |
| 112 | TRPM7 | 0.49985174 |
| 113 | MAP3K11 | 0.49576172 |
| 114 | SYK | 0.48980717 |
| 115 | PRKCQ | 0.48004750 |
| 116 | CAMKK1 | 0.47666539 |
| 117 | AKT3 | 0.46495797 |
| 118 | TEC | 0.43949081 |
| 119 | RPS6KA5 | 0.43884105 |
| 120 | MAP2K6 | 0.43286867 |
| 121 | PRKCZ | 0.43282072 |
| 122 | IGF1R | 0.42948280 |
| 123 | JAK1 | 0.41619852 |
| 124 | CSNK1G1 | 0.41034415 |
| 125 | ABL1 | 0.39838627 |
| 126 | TGFBR2 | 0.39742105 |
| 127 | MAPKAPK5 | 0.39699102 |
| 128 | RPS6KB1 | 0.38954923 |
| 129 | BCR | 0.38740200 |
| 130 | KDR | 0.38715819 |
| 131 | MYLK | 0.38130628 |
| 132 | SGK494 | 0.37220886 |
| 133 | SGK223 | 0.37220886 |
| 134 | STK11 | 0.37124322 |
| 135 | GSK3A | 0.37096038 |
| 136 | MAP3K10 | 0.37027212 |
| 137 | PRKAA1 | 0.36541700 |
| 138 | STK3 | 0.36081835 |
| 139 | CDK9 | 0.35948567 |
| 140 | MAP2K7 | 0.35606998 |
| 141 | SGK1 | 0.34922280 |
| 142 | PASK | 0.32975006 |
| 143 | ZAP70 | 0.32829678 |
| 144 | FGFR3 | 0.32311676 |
| 145 | MAP3K1 | 0.32242199 |
| 146 | IKBKB | 0.31864224 |
| 147 | PDGFRA | 0.31858559 |
| 148 | PNCK | 0.30730313 |
| 149 | PRKCA | 0.29916054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70080362 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27692955 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26556503 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.02361497 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.88786551 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85705325 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65622179 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56736218 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55848353 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48773591 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44218236 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.35425330 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.26878441 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.26303965 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20866391 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15164673 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.13217118 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11821672 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10732289 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07508603 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06664624 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05733041 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99431280 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93971833 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90680259 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85349637 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83633051 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83273428 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.76074101 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74075514 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.67956066 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.66522637 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64183083 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62025694 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57516782 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.55445525 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52012277 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51958959 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49956185 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.46217915 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44465716 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43903289 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43659434 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42112846 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.41497763 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39455762 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38894692 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38814036 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34718048 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33836842 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29720481 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26725176 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25402608 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 1.24639687 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24474934 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22489907 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20797542 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19076022 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16735628 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.15641927 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11426166 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09151964 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04006291 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03520303 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02371296 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01843061 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01792460 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.99179260 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98334787 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97374433 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94436478 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94017712 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91044393 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84837944 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81326415 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.80368255 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79813326 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79259940 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78425410 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76236962 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70916510 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70314995 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.70117608 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69719493 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69480052 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65427855 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65067401 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63732664 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63691545 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58403216 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57707929 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55142508 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53153526 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48526843 |
| 95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45664737 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44787277 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44606907 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44213187 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43720526 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43120897 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41771577 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.40911073 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.39668727 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38925145 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38133020 |
| 106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37890122 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37683581 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37649184 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.35741007 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.31313667 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31111250 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29914978 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.29810937 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28578253 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.27015883 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25694431 |
| 117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25419144 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25302282 |
| 119 | Morphine addiction_Homo sapiens_hsa05032 | 0.25002530 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22963449 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.22293619 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.21835407 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19598922 |
| 124 | RNA degradation_Homo sapiens_hsa03018 | 0.18601970 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18506919 |
| 126 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17637370 |
| 127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17461079 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16668688 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.14552634 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14061300 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11805561 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11106963 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10668622 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.10172443 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07127169 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06594940 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.02536767 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02491778 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00160201 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | -0.0644358 |
| 141 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0555228 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | -0.0368907 |
| 143 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0352323 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0284672 |
| 145 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0180074 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0151353 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0082522 |

